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Abstract 
Autophagy is a catabolic process by which the cell targets and degrades cytoplasmic 
materials, such as proteins and organelles. Autophagy is required for the control of 
muscle mass under catabolic conditions, but is also active basally to maintain myofibre 
homeostasis. The purpose of this thesis was to characterize the role of autophagy in the 
maintenance of skeletal muscle morphology and cellular health. A conditional muscle-
specific Atg7 knockdown mouse model was used to examine the morphological, 
apoptotic, proteolytic, and proteasomal response to autophagy deficiency in the glycolytic 
and oxidative skeletal muscle of 5-week and 15-week-old mice. While overt phenotypic 
differences were absent between the autophagy-deficient animals and the controls, 
structural alterations were observed at the fibre level indicating moderate damage. Atg7 
knockdown resulted in significant age-dependent accumulation of the autophagic markers 
LC3I (p<0.001) and p62 (p<0.01) in both oxidative and glycolytic muscle.  Evidence of 
the upregulation of apoptosis was observed in the autophagy-null animals, including Bax 
expression (p<0.05) and nuclear translocation of AIF to the nucleus (p<0.01). The 
proteolytic activities of caspase-8 (p=0.06) and calpain (p<0.05) were also increased with 
autophagy knockdown. Reactive oxygen species (ROS) generation was not affected by 
Atg7 knockdown, nor were markers of mitophagic degradation. Several of the apoptotic 
and mitophagic measures revealed differences between the observed age groups, 
highlighting a role for degradative and cell death processes in skeletal muscle growth and 
development. Together, these findings point towards moderate but accumulative damage 
in autophagy-ablated skeletal muscle. The present work contributes to the existing 
literature demonstrating the importance of autophagy in the maintenance of skeletal 
muscle health.   
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Introduction 
Muscle mass is maintained through a balance between protein breakdown and synthesis  
[1]. This homeostatic balance is altered in skeletal muscle in a number of conditions including 
starvation, physical activity, disuse, and disease  [1, 2]. In mammalian skeletal muscle, the 
breakdown of proteins is mediated by two proteolytic systems: the autophagy-lysosome system 
and the ubiquitin-proteasome pathway  [1-3]. These systems work in conjunction with 
apoptotic programed cell death to modulate the process of skeletal muscle atrophy  [4].  
Autophagy 
Autophagy is a catabolic process by which the cell targets and degrades cytoplasmic 
materials, such as proteins and organelles  [5]. This process is highly conserved and is critical 
for nutrient balance, cell differentiation, and remodeling  [6]. Cellular materials to be degraded 
are sequestered in the autophagosome, a double-membrane vesicle, subsequently fusing with a 
lysosome where the contents are broken down by lysosomal proteases  [7]. This process is 
specifically referred to as macro-autophagy, herein referred to as autophagy. Micro-autophagy 
and chaperone-mediated autophagy also degrade proteins in conjunction with the lysosome, 
but play a lesser role in overall protein turnover  [7, 8]. Autophagy was thought to be a bulk, 
non-specific degradation process; however, increasing evidence suggests that specific 
cytoplasmic contents can be targeted for degradation  [5].  
Through yeast genetics research, a number of autophagy-related (abbreviated to Atg) 
genes have been characterized  [9]. These genes are well conserved, and mammalian orthologs 
for most have been identified  [5, 9]. Autophagy begins with the formation of an isolation 
membrane (phagophore), a process that is thought to be initiated at the endoplasmic reticulum 
(ER) membrane  [7] (Figure 1). The isolation membrane is elongated through the addition of 
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further membrane components, shuttled by Atg9  [5, 10]. In mammals, the initiation of 
autophagosome formation requires the activity of Vps34 (vesicular protein sorting 34), a 
phosphatidylinositol-3-kinase  [5]. Vps34 is involved in a variety of membrane sorting 
processes, but when complexed to Beclin-1 (Atg6) plays a key role in the elongation of the 
early autophagic membrane  [7, 11]. Beclin-1 regulates the formation and fusion of the 
autophagosome through interactions with a number of signalling molecules  [11]. Of note is 
Bcl-2, the anti-apoptotic BH protein (define BH protein) that blocks the interaction between 
Beclin-1 and Vps34, thereby inhibiting the induction of autophagosome formation  [7, 12, 13].  
 
 
Figure 1. Overview of autophagosome formation and fusion with the lysosome. The 
autophagosome forms around the targeted cellular components and fuses with the lysosome. Lysosomal 
hydrolases are released, degrading the autophagic cargo. Adapted from Xie & Klionsky, 2007  [14]. 
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Following initiation, signaling from two conjugation systems promotes elongation of 
the growing autophagosome  [7, 15] (Figure 2). Atg12 is activated by the enzyme Atg7 then 
transferred to Atg10, after which it covalently binds to Atg5. This complex forms a conjugate 
with Atg16 to form a large tetramer  [5, 8].   
The second cascade associated with the growing autophagosome surrounds the protein 
microtubule-associated protein 1 light chain 3 (LC3). LC3I refers to the cytosolic, or 
unconjugated, form of LC3. LC3II is conjugated to the phosphatidylethanolamine (PE) 
residues of the growing autophagosome membrane through a reaction with Atg7 and Atg3  [5, 
15]. This process requires association with the Atg5-Atg12/Atg16 tetramer  [16]. While the 
Atg12-Atg5/Atg16 complex dissociates from the fully formed autophagosome, LC3II, the PE-
conjugated form of LC3, remains as part of the autophagosome until its fusion with the 
lysosome  [5]. At this point, LC3 molecules on the cytoplasmic side of the autophagolysosome 
can be delipidated by Atg4 and recycled  [5, 15]. Because of the specific association of LC3 
with the autophagosomal membrane, the ratio of LC3II to LC3I is considered an essential 
marker of autophagic flux  [17].  
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Figure 2. The Atg5-Atg12 and LC3-PE ubiquitin-like cascades share components. Adapted 
from Ravikumar et al., 2010  [5]. 
 
 Lysosomal-associated membrane proteins (LAMP) also play a role in the integration of 
the lysosomal and autophagosomal membranes  [8]. Once the two vesicles are fused, 
lysosomal cathepsins and other lysosomal proteases degrade the autophagic cargo and inner 
membrane of the autophagosome  [8, 9]. 
Proteins and organelles may be degraded through autophagy for a variety of reasons, 
but their delivery to the autophagosome always involves tagging with the small protein 
ubiquitin, a process termed ubiquitination  [18]. Ubiquitinated proteins destined for the 
autophagosome are bound by the ubiquitin-associated domain of the protein p62, which itself 
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is recruited by LC3 through its LC3-interacting region  [19, 20]. p62 is then degraded with the 
contents of the autophagosome upon lysosomal digestion; as such, accumulation of p62 is a 
characteristic marker of impaired autophagy  [21].      
Apoptosis 
Apoptosis is a highly conserved process of programmed cell death that is required for 
normal tissue development and homeostasis  [22, 23]. Apoptosis can be triggered by 
intracellular mechanisms mediated by a cascade of caspases, proteolytic enzymes that target 
aspartic acid residues. Once cleaved and activated from their inactive procaspase form, 
initiator caspases (caspase-8, -9, and -12) cleave executioner caspases (caspase-3, -6, or - 7), 
thus amplifying the apoptotic signal  [24, 25]. Executioner caspases cleave targets such as 
cytoskeletal proteins and DNA repair enzymes, resulting in structural and genomic breakdown, 
ultimately leading to cell death  [26]. 
ER stress, such as that caused by an accumulation of misfolded proteins, can also 
trigger cell death by apoptosis. In these cases, the release of excess calcium from the ER 
activates calcium-dependent proteases known as calpains that in turn, activate procaspase 12  
[22, 27]. In skeletal muscle, the pumps and channels involved in the movement of calcium in 
and out of the sarcoplasmic reticulum (SR) during contraction are also involved in apoptotic 
signaling  [28].     
Mitochondria play a key role in intracellular initiation of apoptosis  [29]. A variety of 
cell stressors can result in the loss of mitochondrial membrane potential and the subsequent 
segregation of damaged mitochondria through fission  [30]. In response to apoptotic stimuli, 
pro-apoptotic members of the Bcl-2 family Bax and Bak undergo a conformational change 
causing them to insert in the outer mitochondrial membrane, forming a pore  [31, 32]. 
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Cytochrome c is released from the mitochondria through this pore  [33]. Anti-apoptotic 
members of the Bcl-2 family of proteins, Bcl-2 and Bcl-XL, inhibit apoptosis by blocking the 
release of mitochondrial contents  [22, 34, 35]. Cytochome c initiates the formation of the 
apoptosome with the apoptotic protease activating factor 1 (Apaf-1) and caspase-9, resulting in 
the activation of the initiator caspase  [23, 25]. 
Apoptosis can also be initiated independently of caspases. Apoptosis-inducing factor 
(AIF) is a mitochondrial flavoprotein located in the intermembrane space, where it plays a role 
in oxidative phosphorylation  [36, 37]. Following apoptotic stimulus, the mitochondrial 
membrane is permeabilized and AIF is cleaved from its inner mitochondrial membrane (IMM) 
anchor, released into the cytosol through Bax/Bak pores, and translocated into the nucleus 
where it causes chromatin condensation and DNA cleavage  [37, 38]. This mechanism is 
calcium-dependent; in fact, calpains are a major processor of AIF  [37]. Furthermore, stressors 
such as oxidative damage render mitochondrial AIF more vulnerable to cleavage from the 
IMM  [39, 40].  
Cross-talk between autophagy and apoptosis 
Extensive research has shown that autophagy and apoptosis are not mutually exclusive 
pathways, but share several upstream regulators and key effectors  [41]. Many findings support 
the hypothesis that autophagy antagonizes apoptosis by removing damaged cell components 
and cycling nutrients, processes promoting cell survival  [41, 42]. Cells undergoing nutrient 
starvation require autophagic clearance in order to avoid apoptosis  [43], a process that may be 
modulated by Bcl-2  [44]. Conversely, there is evidence that autophagy and apoptosis work 
jointly to maintain homeostasis, specifically through the interaction of autophagic initiator 
Beclin-1 and the anti-apoptotic Bcl-2 family of proteins  [11, 45]. In this model, the two 
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processes also have the potential to cooperate to induce cell death  [41].  In a similar fashion, 
autophagic degradation can also lead to cell death, a phenomenon termed “autophagic cell 
death” [46]. This cell death process has been observed in cultured cells with impaired apoptotic 
pathways  [47, 48], and may play a role in tumour cell responses to cytotoxic treatments  [46]. 
Controversy on the physiological relevance of autophagic cell death continues as it has only 
been defined in vivo in cells lacking key apoptotic effectors  [49-51]. 
The ubiquitin-proteasome system 
The ubiquitin-proteasome system (UPS) is responsible for the ATP-dependent 
degradation of damaged, denatured, or unnecessary proteins and polypeptides, as well as the 
removal of subunits in the regulation of larger protein complexes  [52]. This process is 
characterized by tagging with ubiquitin  [53]. Similarly to the autophagosome-elongating 
conjugation systems characterized in autophagic degradation, three enzymes coordinate the 
addition of ubiquitin molecules to target proteins, beginning with E1 ubiquitin-activating 
enzymes  [54]. Subsequently, ubiquitin is transferred to an E2 ubiquitin-conjugating enzyme 
and bound to a target protein by E3 ubiquitin ligases  [53, 54]. This process of activation, 
conjugation, and ligation is repeated until a minimum of four ubiquitin molecules are 
covalently bound to the target protein  [53]. The polyubiquitin chain tags proteins for 
degradation by the 26S proteasome, a large protease complex consists of a 19S regulatory 
particle responsible for the binding and unfolding of target proteins and the 20S proteolytic 
core  [55-57]. 
The proteasome is a key effector of muscle degradation, and is spatially associated with 
myofibrils  [52]. More precisely, muscle-specific E3 enzymes target sarcomeric structural 
proteins  [58-60], as well as key protein synthesis and muscle differentiation factors  [61]. The 
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most widely examined are muscle-specific ring finger-1 (MuRF1) and muscle atrophy F-box 
(MAFbx). Often termed ‘atrogenes’, these proteins were initially found to be upregulated in 
murine muscle undergoing atrophy due to starvation or disuse  [58, 62], and were more 
recently shown to play a role in a variety of disease-related models of atrophy  [53, 63].  
The role of mitochondria in skeletal muscle degradation 
Several proteins mediating the selective autophagy of mitochondria, or mitophagy, 
have been characterized in yeast, but a similar depth of understanding remains to be achieved 
in higher eukaryotes  [64]. By removing dysfunctional mitochondria and altering the 
mitochondrial network, this process may protect the cell from mitochondrial-mediated damage 
and apoptosis  [64, 65]. As in traditional autophagy, mitochondria targeted for degradation are 
tagged and directed to the autophagosome  [66]. Damaged or dysfunctional mitochondria are 
isolated from the mitochondrial network through fission and tagged for degradation (Figure 3) 
[67, 68]. A recently elucidated mechanism involves PTEN-induced putative protein kinase 1 
(PINK1) and Parkin, proteins first characterized in Parkinson’s disease  [65, 69]. In healthy 
mitochondria, PINK1 is rapidly processed and cleaved at the OMM by the mitochondrial 
protease presenilin-associated rhomboid-like protein (PARL), after which it is degraded by the 
proteasome  [70, 71]. Loss of mitochondrial membrane potential results in the accumulation of 
PINK1 on the OMM  [72], which in turn induces the translocation of Parkin to the 
mitochondria from the cytosol  [73, 74]. In its role as an ubiquitin ligase, Parkin ubiquitinates 
mitochondrial proteins, tagging the organelle for degradation by the core autophagic 
machinery  [69, 75]. In an in vivo model, Parkin was shown to co-localize with LC3  [76]. The 
specific interactions between mitophagic markers and key autophagosome components are 
currently under investigation by multiple groups, but definitive relationships have yet to be 
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established. PINK1 and Parkin are known to interact directly with each other  [77, 78], 
possibly through the phosphorylation of Parkin by PINK1  [79, 80]. Alternatively, voltage-
dependent anion channels (VDAC) have been proposed as docking sites for Parkin in its 
recruitment to defective mitochondria  [81]. p62 plays a role in linking ubiquitinated 
mitochondrial proteins to LC3 and the autophagosome, and may also facilitate the aggregation 
of defective mitochondria for mass clearance [82, 83]. The related Bcl-2 and adenovirus E1B 
19 kDa-interacting protein 3 (BNIP) proteins BNIP3 and BNIP3L/Nix have also been 
implicated in the binding of autophagosome components to defective mitochondria  [84]. In 
reticulocytes, BNIP3L/Nix has been shown to induce mitophagy by causing mitochondrial 
membrane depolarization  [85, 86], while in yeast it directly interacted with LC3  [87].  
Increased markers of mitophagy have been observed in atrophying skeletal muscle, as 
well as in myopathies  [88]. During denervation atrophy, mitochondrial fission and clearance 
through mitophagy are upregulated  [89]; mitochondrial fractions of denervated muscle 
showed increased levels of LC3II  [90]. Parkin may play a key role in skeletal muscle, as it has 
recently been implicated in the activation of proteasomal degradation during denervation  [91]. 
In fact, a murine model of congenital muscular dystrophy with mitochondrial structural 
abnormalities (CMDmt) has shown increased mitochondrial p62 tagging and accumulation of 
PINK1 and Parkin in mitochondrial fractions  [92].     
Degradative processes in skeletal muscle 
Skeletal muscle is highly plastic and has an effective system to remove damaged 
cellular components in response to the stress of contraction  [93]. Autophagy is required for the 
control of muscle mass under catabolic conditions, but is also active basally to maintain 
myofibre homeostasis  [93, 94]. An excess of autophagic flux is detrimental to the muscle, as  
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Figure 3. Mitophagy degrades dysfunctional mitochondria. In healthy mitochondria, the OMM 
protein PINK1 is rapidly degraded by PARL, preventing its accumulation. Damaged mitochondria are 
segregated from the mitochondrial network through fission and are tagged for degradation. When the 
mitochondrial membrane potential is lost (ΔΨm$), PARL is inhibited, resulting in the accumulation of 
PINK1 on the OMM. This recruits Parkin, which acts as a ubiquitin ligase, ubiquitinating a docking 
protein (e.g. VDAC, Nix) to tag the mitochondrion as an autophagic target. Adapted from Kawajiri et 
al., 2011, Narendra & Youle, 2011, and Twig et al., 2008  [75, 95, 96].  
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is seen in atrophy resulting from fasting, disease or disuse  [97, 98]. Conversely, a lack 
of autophagy also leads to damage caused by the accumulation of dysfunctional organelles and 
proteins  [99, 100]. In fact, several myopathies have been shown to be exacerbated by the 
inhibition of autophagy, due to the formation of protein aggregates  [101, 102]. Autophagy 
also allows for skeletal protein turnover in response to exercise  [103, 104]. 
Apoptosis is a key process in the regulation of skeletal muscle mass  [105, 106]. 
Inhibition of apoptosis attenuates the progression of skeletal muscle deterioration and atrophy 
during damaging conditions  [90, 107, 108]. For example, caspases have been found to play a 
necessary role in skeletal muscle atrophy resulting from immobilization  [109, 110]. Caspases 
also contribute directly to protein degradation in wasting conditions by cleaving myofibrillar 
proteins  [111]. Skeletal muscle is composed of terminally differentiated, multinucleated cells 
and, as such, cell death in this tissue is sometimes referred to as ‘myonuclear apoptosis’  [112]. 
In this process, a nucleus and its associated cytoplasmic domain are destroyed, rather than the 
entire cell  [113].  With comparatively high levels of apoptosis inhibitors and other protective 
proteins, this process is tightly regulated in skeletal muscle  [22]. Furthermore, skeletal muscle 
is a highly heterogeneous tissue and differences in apoptotic expression have been observed 
between muscles and fibre types  [114].  
 In an effort to characterize the importance of autophagy in the maintenance of skeletal 
muscle health and structure, a number of groups have made use of skeletal muscle-specific 
autophagy-knockdown mice. Previous work using a constitutive skeletal muscle-specific Atg7 
knockdown mouse model has pointed to a need for autophagy in the maintenance of healthy 
muscle; however, many discrepancies remain to be addressed  [115-118]. This model has 
shown degradative changes in the form of centralized myonuclei, muscle mass loss, 
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force, and decreased muscle cross-sectional area  [116-118]. In contrast to this, a study by Wu 
and colleagues found no phenotypic or degradative differences between skeletal muscle-
specific Atg7 knockdown mice and controls  [115]. Apoptotic nuclei have been found to be 
increased in autophagy-deficient muscle, as have indicators of mitochondrial dysfunction. This 
suggests that these pathways may be mediating the phenotypic changes observed [115, 116]. 
Collectively, the data on this mouse model is ambiguous and further characterization is 
warranted. 
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Rationale 
 
The role of autophagy in skeletal muscle has only recently begun to be elucidated and 
its role in the maintenance of muscle mass and physiology requires further investigation in 
order to characterize the biochemical and molecular pathways and interactions involved. While 
it is known that several forms of atrophy are associated with an upregulation of autophagy, the 
exact role of this process in the progression of muscle degradation remains unclear. The 
existing research is equivocal, suggesting that autophagy may drive the degradation of muscle  
[90, 119, 120], but it is also possible that the selective degradation of cellular components is a 
protective mechanism  [99, 102, 121]. Varied responses to autophagy knockdown in muscle 
have been observed, an inconsistency that may be explained by the diverse muscle types used 
for analysis. Data on skeletal muscle-specific autophagy deficiency are further confounded by 
a disparity in the age of the animals examined. Furthermore, immunohistochemical analysis of 
fibre type-specific cross-sectional areas and fibre type distribution is required for a thorough 
understanding of the importance of autophagy in oxidative and glycolytic muscle. An increase 
in apoptotic nuclei has been found in Atg7 knockdown mice [116], however a thorough 
characterization of apoptotic signalling in autophagy-deficient muscle is lacking. Skeletal 
muscle-specific autophagy-knockdown mice also display mitochondrial dysfunction, 
suggesting that mitochondrial signalling pathways involved in apoptosis may be modulated by 
the autophagic degradation of dysfunctional mitochondria (mitophagy).  
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Purpose and objectives 
Several important questions persist in the characterization of autophagy deficiency in 
skeletal muscle. Therefore, the purpose of this thesis was to characterize the role of autophagy 
in the maintenance of skeletal muscle. Experiments were performed to examine basal 
differences in skeletal muscle morphology, as well as apoptotic, proteasomal, and 
mitochondrial signalling between skeletal muscle-specific autophagy-deficient (mAtg7-/-) and 
control (Flox/Flox) mice at two ages, and in glycolytic and oxidative muscle. Specifically, this 
project was guided by the following objectives: 
1. To describe any phenotypical and morphological differences between mAtg7-/- and 
control animals 
- This was achieved by measuring body weight, muscle weights, muscle cross-
sectional areas and analyzing microscopic images of muscle cross-sections for 
indications of damage 
- Morphological measures included immunohistochemical staining of muscle 
cross-sections to quantify fibre type distribution and fibre type-specific cross-
sectional area 
2. To measure the extent of autophagic impairment caused by the knockdown of Atg7 in 
skeletal muscle 
- This included the measure of autophagosomal and lysosomal components, as 
well as markers of mitophagy 
3. To determine whether the ubiquitin-proteasome system is upregulated in response to 
skeletal muscle-specfic autophagy knockdown 
- This included measurement of muscle-specific ubiquitin ligases 
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4. To thoroughly characterize the apoptotic response in autophagy-deficient skeletal 
muscle 
- This will include measures of key apoptotic proteins, proteolytic enzymes, and 
ROS generation 
5. To characterize any age-dependent differences in the extent of autophagy deficiency in 
skeletal muscle-specific autophagy knockdown animals 
- Previous work on this animal model has used animals at 8 weeks of age  [115, 
116]. In this study, animals were examined at 5 and 15 weeks of age to 
contribute ‘before’ and ‘after’ time points to the existing literature.   
6. To characterize any differences in the effect of autophagy deficiency in glycolytic and 
oxidative Atg7 knockdown muscle 
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Hypothesis 
The hypotheses for this thesis were as follows: 
1. Skeletal muscle of mAtg7-/- animals will have altered autophagic protein expression 
- Expression of Atg7 will be dramatically decreased in the muscles of mAtg7-/- 
mice 
- Atg7 knockdown will be associated with alterations to downstream markers of 
autophagic flux, namely the accumulation of p62 and LC3I 
- mAtg7-/- muscle will show a downregulation of lysosomal markers, such as 
LAMP2  
2. Skeletal muscle of mAtg7-/- animals will have altered mitophagic protein expression 
- In mAtg7-/- muscle, lack of mitochondrial clearance will result in lower cytosolic 
PINK1 levels 
- The mitochondrial-enriched fraction of mAtg7-/- muscle will have increased 
levels the fission marker Drp1 
3. Skeletal muscle of mAtg7-/- animals will have upregulated apoptotic protein expression, 
protease activity, and reactive oxygen species (ROS) generation 
4. mAtg7-/- mice and their muscles will be morphologically different than the control 
littermates 
- Muscle weights, whole muscle cross-sectional areas, and individual fibre areas 
will be lower in mAtg7-/- mice than in the control animals 
- mAtg7-/- muscles will have a greater proportion of fast-twitch fibres than the 
control animals due a slow-to-fast fibre type shift  [122] 
- mAtg7-/- muscle fibres will have a greater proportion of centralized nuclei 
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5. The 15-week-old age groups will show morphological and apoptotic alterations 
compared to the 5-week-old animals 
- The 15-week-old animals will have a higher body weight, individual muscle 
weight, muscle cross-sectional area, and fibre cross-sectional area compared to 
the 5-week-old animals 
- Muscle from 15-week-old animals will show upregulated apoptosis and 
proteolytic enzyme activity 
- The effects of Atg7 knock-down will be exacerbated at 15 weeks compared to 5 
weeks, resulting in increased accumulation of autophagosomal markers (LC3 
and p62) in the 15-week-old mAtg7-/- animals 
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Methods  
The Cre-loxP system 
The Cre protein (causes recombination) is a site-specific recombinase that acts on loxP 
(locus of crossover [x] in P1 bacteriophage) sites. When two loxP sequences in the same 
orientation flank a linear DNA sequence, the recombination event is resolved with the excision 
of the “floxed” sequence  [123]. This characteristic is exploited in the Cre/loxP mouse model, 
in which the gene of interest is flanked by loxP sites and is removed following the expression 
of Cre recombinase under the control of a tissue-specific promoter, ultimately resulting in gene 
knockdown  [123, 124]. Floxed copies of an allele are expressed normally in any tissue but are 
excised only in cells also expressing Cre.  
Animals 
C57Bl/6 mice heterozygous for the floxed Atg7 (Flox/Flox) allele were obtained from 
Dr. Herbert Virgin (Washington University, St. Louis, Missouri). These were bred to carriers 
of a constitutive Cre recombinase allele (Cre) under the control of a skeletal muscle actin 
promoter (B6.Cg-Tg[ACTA1-cre]79Jme/J) (Jackson Laboratories). The resulting offspring 
were heterozygous for the floxed Atg7 allele and carriers of the Cre allele (Flox/Cre). Flox/Cre 
females were bred to the original Flox/Flox males in order to obtain the double transgenic 
experimental animals homozygous for the floxed Atg7 allele and carriers of Cre 
(FloxFlox/Cre). This breeding scheme generated FloxFlox/Cre animals, skeletal muscle-
specific Atg7-null mouse (mAtg7-/-). Flox/Flox littermates were used as controls (Appendix 
Figures 1 & 2). Mice were group-housed with access to water and standard lab rodent chow ad 
libitum (Harlan). mAtg7-/- animals and Flox/Flox controls (n=8) were sacrificed by cervical 
dislocation at 5 and 15 weeks of age in order to characterize any age-dependent changes in 
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autophagy knockdown  [115, 116]. All animal procedures were approved by the University of 
Waterloo Animal Care Committee.  
Genotyping 
To determine genotype, ear notches were collected from 4-week old mice. DNA was 
extracted and purified from the ear notches using the PureLink DNA Extraction Kit 
(Invitrogen) and DNA samples were stored at 4˚C for no more than 48 hours. DNA samples 
were added to a mixture of 2X PCR Taq MasterMix (Applied Biological Materials), sterile 
water, and the appropriate forward and reverse primers for the Atg7 Flox/WT, Atg7 WT, and 
ACTA1-Cre alleles. The sequences of the Atg7 Flox/WT forward and reverse primers are 
5‘TGGCTGCTACTTCTGCAATGATGT3’ and 
5‘CAGGACAGAGACCATCAGCTCCAC3’, respectively. The sequences of the Atg7 WT 
forward and reverse primers are 5‘TCTCCCAAGACAAGACAGGGTGAA3’ and 
5‘AAGCCAAGGAAACCAAGGGAGTG3’, respectively. Forward and reverse primers for 
the ACTA1-Cre allele are 5’GCGGTCTGGCAGTAAAAACTATC3’ and 
5’GTGAAACAGCATTGCTGTCACTT3’, respectively. Protocols for each primer pair were 
optimized (Table 1). 
Table 1. Atg7 loxP genotyping thermocycler protocols 
Atg7 floxed allele 
(Flox/WT) 
Atg7 wild-type allele (WT) ACTA1-Cre recombinase 
94˚C, 5 min 
32 cycles: 94˚C, 20 s 
         68˚C, 30 s 
         72˚C, 1.5 min 
72˚C, 10 min 
4˚C,  ∞ 
94˚C, 5 min 
33 cycles: 94˚C, 20 s 
         60˚C, 15 s 
         72˚C, 1 min 
72˚C, 10 min 
4˚C,  ∞ 
94˚C, 3 min 
26 cycles: 94˚C, 30 s 
         51.7˚C, 1 min 
         72˚C, 1 min 
72˚C, 2 min 
10˚C,  ∞ 
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Following amplification, samples were separated on a 1% agarose gel containing 
0.01% ethidium bromide, then imaged using the ChemiGenius 2 Bio-Imaging System 
(Syngene). 
Isolation of skeletal muscle 
Extensor digitorum longus (EDL), soleus, gastrocnemius, and quadriceps were isolated 
and weighed. Cross-sections obtained from the EDL and soleus were frozen in optimal cutting 
temperature (OCT) embedding media for sectioning and histological and immunofluorescent 
analysis. The soleus and EDL were chosen as representative primarily red and primarily white 
muscles, respectively (Appendix Figure 5). The remainder of the muscles were snap-frozen in 
liquid nitrogen and stored at -80˚C until analysis. The gastrocnemius and quadriceps were 
separated into red or white portions, containing oxidative and glycolytic muscle, respectively 
(Appendix Figure 3). These samples were also snap-frozen in liquid nitrogen and stored at        
-80˚C. Total body weight, heart weight, as well as kidney weight were recorded.  
Histological and immunofluorescent analyses 
Samples were cut in 10 µm cross-sections with a cryostat (Thermo Electronic) as 
previously described  [114, 125]. Slides were stained with hematoxylin and eosin (H&E) to 
visualize markers of degradation and damage, specifically centrally located nuclei. Images 
were taken of the four quadrants of each H&E-stained section. The percentage of centrally-
located nuclei was quantified as a percentage of the total number of fibres counted in these 
images. 
Slides were stained for myosin heavy chain expression (MHC) as previously described  
[126] using antibodies against MHCI (BA-F8), MHCIIA (SC-71), and MHCIIB (BF-F3). 
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Slides were visualized using an Axio Observer Z1 microscope equipped with an AxioCam 
HRm camera and AxioVision software (Carl Zeiss). Individual images were taken across the 
entire cross-section and assembled into a composite image using AxioVision software (Carl 
Zeiss) and analyzed using ImageJ. 
Fibre counts, fibre type percentages and individual fibre and full muscle cross-sectional 
area (CSA) were determined. For fiber type analysis, all fibres within the entire muscle/cross-
section were characterized. Fibre CSA measurements included at least 30 fibres of each fibre 
type within a cross-section. 
Preparation of whole muscle lysates and muscle subcellular fractions 
Whole muscle lysates of white and red quadriceps were prepared as previously 
described  [114]. Samples were homogenized with a glass mortar and pestle in ice-cold lysis 
buffer (20 mM HEPES, 10 mM NaCl, 1.5 mM MgCl, 1 mM DTT, 20% glycerol, and 0.1% 
Triton X100; pH 7.8), protease inhibitors (Complete Cocktail; Roche Diagnostics), and 
phosphatase inhibitors (Halt Phosphatase Inhibitor Cocktail; Thermo Scientific). Subsequently, 
samples were centrifuged at 1000 g for 10 minutes at 4˚C, and the supernatant was collected.  
A BCA protein assay was used to determine the protein content of each sample.  
Subcellular fractions were prepared as previously described  [114, 127]. Brieﬂy, muscle 
was gently homogenized on ice in a subcellular fractionation buffer (250 mM sucrose, 20 mM 
HEPES, 10 mM KCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT; pH 7.4) with protease 
(Complete Cocktail; Roche Diagnostics) and phosphatase inhibitors (Halt Phosphatase 
Inhibitor Cocktail; Thermo Scientific). The resulting homogenates were centrifuged at 800 g at 
4°C for 10 min, yielding a pellet (P1) and supernatant (S1). The S1 fraction was then 
centrifuged at 800 g at 4°C for 10 min again, and the supernatant was transferred to a new tube 
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(S2). The S2 fraction was centrifuged at 20,800 g at 4°C for 20 min, yielding a pellet 
containing mitochondria (M1) and the cytosolic supernatant (C1). The M1 pellet was washed 
with subcellular fractionation buffer and centrifuged at 16,000 g at 4°C for 20 min. This pellet 
is the mitochondrial-enriched fraction. The cytosolic (C1) supernatant was centrifuged at 
20,800 g at 4°C for 20 min to ensure that it contained no residual mitochondria. The resulting 
supernatant is the cytosolic-enriched fraction. The P1 pellet was washed and centrifuged three 
additional times at 800 g at 4°C for 10 min. Lysis buffer (200 µl) and 5 M NaCl (27.7 µl) was 
added to the resulting pellet and rotated for 1 h at 4°C, following which the samples were 
centrifuged at 20,800 g at 4°C for 15 min. The supernatant is the nuclear-enriched fraction. 
The protein concentration of each subcellular fraction was determined with a BCA protein 
assay. The purity of the subcellular fractions obtained was determined by immunoblotting 
(Appendix Figure 7). 
Immunoblot analyses 
SDS-PAGE gel electrophoresis and western blotting were performed as previously 
described  [114]. Briefly, protein samples of equal amounts were loaded and separated on 10%, 
12%, or 15% SDS-PAGE gels, transferred onto PVDF membranes (Bio-Rad), and blocked in 
5% milk in TBS-T for 1 hour at room temperature. Membranes were incubated either 
overnight at 4˚C or for 1 hour at room temperature in primary antibodies against: Atg7, 
LC3I/II, PINK1, Drp1 (Cell Signaling), AIF, ANT, Bcl-2, Beclin-1, cytochrome c, MAFbx, 
MuRF1, histone H2B (Santa Cruz Biotechnology), Bax (Sigma-Aldrich), CuZnSOD, Smac 
(Enzo Life Sciences), LAMP2 (Developmental Studies Hybridoma Bank), and p62 (ProGen 
Biotechnik). 
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Membranes were washed with TBS-T and incubated for 1 hour at room temperature in 
the appropriate horseradish peroxidase (HRP)-conjugated secondary antibody (Santa Cruz 
Biotechnology). Proteins were visualized using the Clarity Western ECL substrate (Bio-Rad) 
and the ChemiGenius 2 Bio-Imaging System (Syngene). Membranes were subsequently 
stained with Ponceau S (Sigma-Aldrich) to ensure quality of sample loading and protein 
transfer.       
Enzyme and protease activity 
Enzyme and protease activity were measured as previously described  [114]. To 
determine calpain activity, white and red gastrocnemius muscle homogenates were prepared 
without protease inhibitors and were incubated in duplicate in the dark at 37˚C with the 
substrate Suc-LLVY-AMC (Enzo Life Sciences), with or without the specific calpain inhibitor 
Z-LL-CHO (Enzo Life Sciences) [114]. Using excitation and emission wavelengths of 360 nm 
and 440 nm, respectively, fluorescence was measured using the SPECTRAmax Gemini XS 
microplate spectrofluorometer (Molecular Devices). 
To assess cathepsin activity, muscle homogenates were prepared without protease 
inhibitors and incubated in duplicate in the dark at 30°C in reaction buffer (50 mM sodium 
acetate, 8 mM DTT, 4 mM EDTA, 1 mM Pefabloc; pH 5.0) with 50 µM of the fluorogenic 
substrate z-FR-AFC (Enzo Life Sciences). Using excitation and emission wavelengths of 400 
nm and 489 nm, respectively, fluorescence was measured at 30°C using a SPECTRAmax 
Gemini XS microplate spectrofluorometer (Molecular Devices). 
Caspase-3, 8, and 9 activity were determined in duplicate in muscle homogenates using 
Ac-DEVD-AMC, Ac-IETD-AMC, and Ac-LEHD-AMC caspase substrates, respectively 
(Enzo Life Sciences). Muscle homogenates were prepared without protease inhibitors and 
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incubated in the dark in the appropriate substrate at room temperature. Using a SPECTRAmax 
Gemini XS microplate spectrofluorometer (Molecular Devices), measures of fluorescence 
were made at 15-minute intervals for 2 hours with excitation and emission wavelengths of 360 
nm and 440 nm, respectively.  
All enzymatic activity fluorescence measurements were standardized to total protein 
content and expressed as AU per milligram of protein. 
Measurement of reactive oxygen species generation 
 The generation of reactive oxygen species (ROS) was quantified as previously 
described  [128]. Briefly, white and red gastrocnemius muscle ROS generation was determined 
using dichlorofluorescein-diacetate (DCFH-DA), a compound hydrolyzed by cellular esterases 
to form nonfluorescent DCFH, which can then be oxidized by a variety of ROS to the highly 
fluorescent DCH. Muscle was homogenized using a glass mortar and pestle in ice-cold 
subcellular fractionation buffer (250 mM sucrose, 20 mM HEPES, 10 mM KCl, 1 mM EDTA, 
1 mM EGTA, 1 mM DTT; pH 7.4) along with protease inhibitors (Complete Cocktail, Roche 
Diagnostics). Muscle homogenates were incubated in duplicate. DCF fluorescence was 
detected with a SPECTRAmax Gemini XS microplate spectrofluorometer (Molecular Devices) 
with excitation and emission wavelengths of 490 nm and 525 nm, respectively. Fluorescence 
intensity was standardized to total protein content and expressed as AU per milligram of 
protein. 
Statistical analysis 
All results are given as means ± SEM. Western blot and enzymatic activity assay data 
are standardized to the 5-week-old control group. Data were analyzed using two-way analyses 
 25 
of variance (ANOVA), with p<0.05 considered statistically significant and p=0.05 to 0.09 
considered a statistical trend. ANOVA interaction effects were assessed using the Tukey HSD 
post-hoc test. All statistical analyses were performed using Prism 5 statistical software.     
  
 26 
Results  
Generation of muscle-specific Atg7 knockdown animals 
 Transgenic mice were generated with copies of Atg7 flanked by loxP sites, as well as 
copies of Cre recombinase (FloxFlox/Cre), resulting in skeletal-muscle specific knockdown of 
Atg7 (mAtg7-/-). These animals were identified through PCR analysis (Figure 4A). In mAtg7-/- 
white quadriceps (WQ), protein expression of Atg7 was reduced compared to Flox/Flox 
controls (CTRL) by 79% at 5 weeks of age, and 85% at 15 weeks (p<0.001, Figure 4B). In the 
red quadriceps (RQ), Atg7 expression was reduced by 71% at 5 weeks and 83% in the 15-
week-old group (p<0.001, Figure 4C). Cardiac muscle showed no significant decrease in Atg7 
expression (p=0.454, Appendix Figure 4).  
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Figure 4. Generation of mAtg7-/- animals. A: PCR analysis of Atg7 Flox (500bp), Atg7 WT (300 
bp), and ACTA1-Cre (100 bp) gene expression. B: Quantification of Atg7 protein expression in the 
white quadriceps (WQ) and red quadriceps (RQ) of mAtg7-/- animals (KD) and Flox/Flox controls 
(CTRL). C: Representative immunoblots of Atg7 protein expression in WQ and RQ of KD and CTRL 
animals. Actin immunoblots and ponceau-stained membranes are shown as an example of loading and 
transfer consistency (n = 8, *** main effect p<0.001 vs. CTRL, † main effect p<0.05 vs. 5-week 
group). 
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Morphological measures and histological observations 
In both mAtg7-/- and control animals, there was a main effect of age in body weight 
(Table 2, p<0.001). While autophagy deficiency did not alter body weight (p=0.76), control 
animals increased in body weight by 49% between 5 and 15 weeks, while mAtg7-/- animals 
grew only by 33%. Similarly, the soleus weight of control animals increased by 53%, while 
autophagy-deficient soleus weight was only increased by 22%. The same trend was seen in 
EDL, with 46% and 33% growth in the control and knockdown animals, respectively. This 
effect was not seen to the same extent in quadriceps, with 71% and 72% growth in the control 
and knockdown animals, respectively. There was also an effect of age in wet muscle weights 
for soleus (SOL), EDL, and quadriceps (p<0.001). Normalizing SOL and EDL wet muscle 
weights to heart or kidney weight negated the age-based differences; however, the effect 
persisted in the quadriceps (p<0.001).  
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Table 2. Anthropomorphic characteristics of control and mAtg7-/- animals. Data are expressed as 
means ± SEM (n=8, ††† main effect p<0.001 vs. 5-week group). 
 
  5 weeks 15 weeks 
 CTRL KD CTRL KD 
Body weight (g)   18.84 ± 0.774 19.90 ± 0.730 28.04 ± 0.550 26.54 ± 0.694   ††† 
Muscle weight 
(mg) 
SOL 5.88 ± 0.385 7.36 ± 0.510 8.98 ± 0.218 9.00 ± 0.402     ††† 
EDL 6.12 ± 0.360 6.46 ± 0.428 8.92 ± 0.331 8.60 ± 0.477     ††† 
QUAD 105.73 ± 5.615 108.34 ± 7.254 181.08 ± 5.695 186.65 ± 6.446  ††† 
Muscle weight/ 
heart weight (mg) 
SOL 0.066 ± 0.004 0.080 ± 0.004 0.077 ± 0.003 0.072 ± 0.004 
EDL 0.069 ± 0.003 0.073 ± 0.004 0.077 ± 0.003 0.069 ± 0.005 
QUAD 1.180 ± 0.030 1.169 ± 0.048 1.553 ± 0.039 1.486 ± 0.040    ††† 
Muscle weight/ 
kidney weight 
(mg) 
SOL 0.054 ±0.004 0.062 ± 0.003 0.060 ± 0.003 0.060 ± 0.003 
EDL 0.056 ±0.004 0.057 ± 0.002 0.060 ± 0.004 0.057 ± 0.003 
QUAD 0.945 ± 0.026 0.910 ± 0.034 1.201 ± 0.047 1.246 ± 0.067    ††† 
 
Histological examination of soleus and EDL cross-sections revealed no significant 
differences in total cross-sectional area (CSA) in either soleus or EDL (Figure 5). In the soleus, 
fibre type-specific cross-sectional area measurements showed a significant effect of age in type 
I (p<0.05), type IIA and hybrid type IIX/IIB (p<0.001), as well as hybrid type IIA/IIX and type 
IIX (p<0.01). There was a trend to significance in fibre type I/IIA CSA (p=0.05). Type IIX 
CSA was also larger in mAtg7-/- animals compared to controls (p<0.05) (Figure 6 and 7A). In 
the EDL, type IIA (p<0.05), IIA/IIX, IIX, IIX/IIB, and IIB (p<0.001) fibres were larger in 15-
week-old animals compared to the 5-week age group. Type I/IIA fibres also tended to have a 
larger CSA in the older group (p=0.07). Type IIA fibre CSA tended to be higher in mAtg7-/- 
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animals compared to controls (p=0.07) and type IIX fibre CSA was significantly higher in the 
knockdown animals (p<0.05) (Figure 8 and 9A). 
 
Figure 5. Total cross-sectional area of mAtg7-/- muscle. A: Total muscle cross-sectional area in 
soleus (SOL) of mAtg7-/- animals (KD) and Flox/Flox controls (CTRL). B: Total muscle cross-sectional 
area in extensor digitorum longus (EDL) in KD and CTRL animals. (n=6-8). 
 
Total fibre number and fibre type distribution were also quantified. In the soleus, 15-
week-old had a higher percentage of type I fibres and a lower percentage of type IIA/IIX fibres 
compared to their 5-week-old counterparts (p<0.05). Knockdown animals had a lower 
proportion of I and I/IIA fibres and a higher proportion of type IIX fibres compared to controls 
(p<0.05) (Figure 7B). 15-week-old animals had a higher percentage of EDL type IIA fibres 
(p<0.05) and tended to have a lower percentage of hybrid type I/IIA fibres (p=0.08) (Figure 
9B).  
 
(Next page) Figure 6. Representative immunohistochemical images of mAtg7-/- soleus muscle. 
A-D: Representative images of soleus whole muscle cross-sections from Flox/Flox controls (CTRL) 
and mAtg7-/- (KD) animals stained with antibodies specific for the individual myosin heavy chain 
isoforms: type I (blue), type IIA (green), type IIB (red), type IIX (unstained). Left to right: 5 week 
CTRL, 5 week KD, 15 week CTRL, 15 week KD. Scale bars indicate 200 µm.  E: Magnified images of 
EDL muscle cross-sections from CTRL and KD animals. Scale bar indicates 50 µm.
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Figure 7. Immunohistochemical analyses of mAtg7-/- soleus muscle. A: Fibre type-
specific cross-sectional area in soleus (SOL) muscle of mAtg7-/- animals (KD) and 
Flox/Flox controls (CTRL). B: Fibre type distribution (percentage of total fibres) in the 
SOL of KD and CTRL animals (n=6-8, * main effect p<0.05 vs. CTRL, † main effect 
p<0.05 vs. 5 week group, †† main effect p<0.01 vs. 5- week group, ††† main effect 
p<0.001 vs. 5-week group). 
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H&E staining of soleus and EDL cross-sections allowed for the quantification of 
centralized myonuclei, a hallmark of fibres recovering from muscle damage [129] 
(Figure 10A). mAtg7-/- soleus showed 0.4% and 0.5% more centralized nuclei compared 
to control muscle at 5 and 15 weeks respectively; however, these findings were not 
statistically significant (Figure 10B). In the EDL at 5 weeks of age, mAtg7-/- had 0.6% 
more centralized nuclei compared to controls. With an increase 0f 2.0% compared to 
controls, 15-week-old EDL muscle had higher percentage of centrally located nuclei than 
all other groups (p < 0.001, Figure 10C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Next page) Figure 8. Representative immunohistochemical images of mAtg7-/- EDL 
muscle. A-D: Representative images of extensor digitorum longus (EDL) whole muscle cross-
sections from Flox/Flox controls (CTRL) and mAtg7-/- (KD) animals stained with antibodies 
specific for the individual myosin heavy chain isoforms: type I (blue), type IIA (green), type IIB 
(red), type IIX (unstained). Left to right: 5 week CTRL, 5 week KD, 15 week CTRL, 15 week 
KD. Scale bars indicate 200 µm.  E: Magnified images of EDL muscle cross-sections from 
CTRL and KD animals. Scale bar indicates 50 µm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 34 
 
 35 
 
Figure 9. Immunohistochemical analyses of mAtg7-/- EDL muscle. A: Fibre type-specific 
cross-sectional area in extensor digitorum longus muscle (EDL) of mAtg7-/- animals (KD) and 
Flox/Flox controls (CTRL). B: Fibre type distribution (percentage of total fibres) in the EDL of KD 
and CTRL animals (n=6-8, * main effect p<0.05 vs. CTRL, † main effect p<0.05 vs. 5-week group, 
††† main effect p<0.001 vs. 5-week group). 
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Figure 10. Analysis of H&E-stained cross-sections of mAtg7-/- muscle. A: Semi-quantitative 
measure of centralized myonuclei in control (CTRL) and mAtg7-/- (KD) soleus and EDL, expressed as 
the percentage of the fibres counted showing a central nuclei. B: Representative H&E stained soleus 
cross-sections. C: Representative H&E stained EDL cross-sections. Arrowheads indicate centralized 
myonuclei. Scale bar indicates 50 µm (n=7-8, §§§ interaction effect p < 0.001 vs. all).  
 
Autophagic and mitophagic protein expression 
 In order to characterize the effect of Atg7 knockdown in oxidative and glycolytic 
muscle, the expression of downstream components of the autophagic machinery was quantified 
in whole muscle homogenate. The ubiquitin-binding protein p62 accumulated in the 
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autophagy-deficient animals, with the 15-week-old knockdown animals having significantly 
higher levels compared to all other groups in both WQ and RQ muscle (p<0.001, Figure 11A). 
The 15-week-old knockdown animals also had significantly higher expression of the unbound 
cytosolic isoform of LC3, LC3I, compared to all other groups in the WQ (p<0.001) and RQ 
(p<0.01). Knockdown muscle had significantly lower levels of the autophagosome-associated 
lipidated isoform, LC3II, in the WQ (p<0.01) and RQ  (p<0.05). Expressed as a ratio of 
autophagosomal-to-cytosolic LC3 (LC3II:I), the WQ of 15-week-old control animals had a 
higher ratio compared to all other groups (p<0.001). The RQ LC3II:I ratio was significantly 
decreased in the knockdown animals compared to controls (p<0.01, Figure 11B). 
 The expression of Beclin-1, a key regulator of autophagosome formation, was 
measured. WQ Beclin-1 expression was significantly elevated in knockdown animals 
(p<0.001). In the RQ, 15-week-old animals showed reduced Beclin-1 expression compared to 
their 5-week-old counterparts (p<0.001, Figure 11C). 
 
 
 
(Next page) Figure 11. Expression of autophagic markers in mAtg7-/- muscle. A: Quantification 
of p62 protein expression in the white quadriceps (WQ) and red quadriceps (RQ) of mAtg7-/- animals 
(KD) and Flox/Flox controls (CTRL).  B: Quantification of LC3I and LC3II protein expression in the 
WQ and RQ of KD and CTRL animals. The calculated LC3II:I ratio is also shown. C: Quantification of 
Beclin-1 protein expression in the WQ and RQ of KD and CTRL animals. D: Representative 
immunoblots of p62, LC3, and Beclin-1 expression in the WQ and RQ of KD and CTRL animals.  
Actin immunoblots and ponceau-stained membranes are shown as an example of loading and transfer 
consistency (n=4-8,	  §§§ interaction effect p<0.001 vs. all,	  §§ interaction effect p<0.01 vs. all, * main 
effect p<0.05 vs. CTRL, ** main effect p<0.01 vs. CTRL, *** main effect p<0.001 vs. CTRL, ††† 
main effect p<0.001 vs. 5-week group). 
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The effect of autophagy knockdown on autophagolysosomal fusion and subsequent 
cargo degradation was assessed through quantification of LAMP2 protein expression and the 
enzymatic activity of lysosomal cathepsins. While there were no significant differences across 
the groups in the expression of LAMP2 in the WQ, expression in the RQ of 15-week-old 
animals was significantly reduced compared to the 5-week group (p<0.05, Figure 12A). In 
both the white gastrocnemius (WG) and red gastrocnemius (RG), 15-week-old animals showed 
lower maximal cathepsin activity compared to the 5-week-old age group (p<0.001, Figure 
12C). 
Mitophagic degradation was characterized by quantifying the level of cleaved PINK1 
in the cytosolic fraction. There were no significant differences in cytosolic PINK1 levels in 
either muscle type (Figure 13A). While there were no differences between groups in the levels 
of the GTPase Drp1 in the mitochondrial-enriched fractions of WQ, mitochondrial Drp1 was 
elevated in the RQ of 15-week-old animals compared to the 5-week-old age group (p<0.001, 
Figure 13C). 
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Figure 12. Expression of lysosomal markers in mAtg7-/- muscle. A: Quantification of LAMP2 
protein expression in the white quadriceps (WQ) and red quadriceps (RQ) of mAtg7-/- animals (KD) and 
Flox/Flox controls (CTRL). B: Representative immunoblots of LAMP2 expression in the WQ and RQ 
of KD and CTRL animals. Actin immunoblots and ponceau-stained membranes are shown as an 
example of loading and transfer consistency. C: Quantitative analysis of maximal cathepsin enzymatic 
activity in the white gastrocnemius (WG) and red gastrocnemius (RG) of KD and CTRL animals (n=6-
8, † main effect p<0.05 vs. 5-week group, ††† main effect p<0.001 vs. 5-week group).  
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Figure 13. Expression of mitophagic markers in mAtg7-/- muscle. A: Quantification and 
representative immunoblot of PINK1 protein expression in the cytosolic fraction of the white 
quadriceps (WQ) and red quadriceps (RQ) of mAtg7-/- animals (KD) and Flox/Flox controls (CTRL). B: 
Quantification and representative immunoblot of Drp1 protein expression in the mitochondrial-enriched 
fraction of the WQ and RQ of KD and CTRL animals. Actin and ANT immunoblots and ponceau-
stained membranes are shown as an example of loading and transfer consistency  (n=4-8, ††† main 
effect p<0.001 vs. 5-week group).  
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UPS signalling and proteolytic activity 
 The activity of the UPS was assessed by measuring the expression of the muscle-
specific ubiquitin ligases MuRF1 and MAFbx. WQ MuRF1 expression was significantly 
higher in 15-week-old animals compared to their 5-week-old counterparts (p<0.01). There 
were no differences between groups in the RQ expression of MuRF1 (Figure 14A). MAFbx 
levels were elevated in the WQ of 15-old-animals compared to the 5-week-old group (p<0.05), 
and RQ levels tended to be higher in the 15-week-old age group (p=0.08, Figure 14B). 
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Figure 14. Expression of markers of the ubiquitin-proteasome system in mAtg7-/- muscle. A: 
Quantification of MuRF1 protein expression in the white quadriceps (WQ) and red quadriceps (RQ) of 
mAtg7-/- animals (KD) and Flox/Flox controls (CTRL). B: Quantification of MAFbx protein expression 
in the WQ and RQ of KD and CTRL animals. C: Representative immunoblots of MuRF1 and MAFbx 
expression in the WQ and RQ of KD and CTRL animals. Actin immunoblots and ponceau-stained 
membranes are shown as an example of loading and transfer consistency (n=5-8, † main effect p<0.05 
vs. 5-week group, †† main effect p<0.01 vs. 5-week group).  
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Apoptotic protein expression and enzyme activity 
  To determine whether autophagy knockdown affects apoptotic signaling in skeletal 
muscle, the expression of pro- and anti-apoptotic proteins was measured. The pro-apoptotic 
marker Bax was significantly higher in the WQ of knockdown animals compared to controls 
(p<0.05). In both the WQ and RQ, Bax expression was reduced in the 15-week age group 
compared to the 5-week-old animals (p<0.05, p<0.001; Figure 15A). Bcl-2, an important anti-
apoptotic regulator, was significantly lower in the RQ of 15-week-old animals compared to the 
5-week-old age group (p<0.01). There were no differences across groups in the WQ expression 
of Bcl-2 (Figure 15B). The calculated Bax:Bcl-2 ratio in WQ tended to be significantly higher 
in knockdown animals compared to controls (p=0.086) and lower in 15-week-old animals 
compared to the 5-week-old group (p=0.066). In the RQ, the Bax:Bcl-2 ratio was not different 
between groups (Figure 15C). 
 The release of the mitochondrial protein cytochrome c into the cytosol is an important 
step in the execution of apoptosis  [22]. WQ cytosolic levels of cytochrome c were 28% and 
39% higher in the knockdown animals at 5 weeks and 15 weeks, respectively; however, these 
differences were not statistically significant (p=0.21). In the RQ, 15-week-old animals showed 
elevated cytosolic cytochrome c that trended towards significance (p=0.05, Figure 16A).  
AIF acts in a caspase-independent manner by translocating to the nucleus to cause 
DNA fragmentation and chromatin condensation during apoptosis  [22]. There were no 
differences across groups in the expression of AIF in the nuclear fraction of WQ. In the RQ, 
the 15-week-old knockdown animals had significantly higher levels of nuclear AIF compared 
to all other groups (p<0.01, Figure 16C). 
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Figure 15. Expression of apoptotic markers in mAtg7-/- muscle. A: Quantification of Bax protein 
expression in the white quadriceps (WQ) and red quadriceps (RQ) of mAtg7-/- animals (KD) and 
Flox/Flox controls (CTRL). B: Quantification of Bcl-2 protein expression in the WQ and RQ of KD 
and CTRL animals. C: Representative immunoblots of Bax and Bcl-2 expression in the WQ and RQ of 
KD and CTRL animals. Actin immunoblots and ponceau-stained membranes are shown as an example 
of loading and transfer consistency (n=5-8, * main effect p<0.05 vs. CTRL, † main effect p<0.05 vs. 5-
week group, †† main effect p<0.01 vs. 5-week group, ††† main effect p<0.001 vs. 5-week group).  
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Figure 16. Expression of apoptotic markers in mAtg7-/- muscle subcellular fractions. A: 
Quantification of cytochrome c protein expression in the cytosolic fractions of the white quadriceps 
(WQ) and red quadriceps (RQ) of mAtg7-/- animals (KD) and Flox/Flox controls (CTRL). B: 
Representative immunoblots of cytochrome c expression in the WQ and RQ of KD and CTRL animals. 
C: Quantification of AIF protein expression in the nuclear fractions of the WQ and RQ of KD and 
CTRL animals. D: Representative immunoblots of AIF expression in the WQ and RQ of KD and CTRL 
animals. Actin and histone H2B immunoblots and ponceau-stained membranes are shown as an 
example of loading and transfer consistency (n=7-8, §§ interaction p<0.01 vs. all).  
 47 
 Caspases play instrumental roles during the initiation and execution of apoptosis, both 
by cleaving downstream targets and by directly degrading cellular components  [26]. Caspase-
3 activity was reduced in the 15-week-old animals compared to the 5-week-old age group, in 
both the WG and the RG (p<0.001, Figure 17A). WG and RG capsase-8 activity trended 
towards being significantly elevated in the autophagy-ablated animals compared to controls 
(p=0.06 and p=0.05, respectively). In addition, caspase-8 activity was significantly lower in the 
older age group across both muscle types (p<0.001, Figure 17B). Similarly, caspase-9 activity 
was reduced in the 15-week-old group compared to their 5-week-old counterparts, in both the 
WG and RG (p<0.001, Figure 17C). In the WG, the activity of calcium-dependent proteases 
calpains was significantly higher in the knockdown animals compared to controls (p<0.05), but 
was reduced in the 15-week-old age group compared to the 5-week-old animals (p<0.01). RG 
calpain activity tended to be lower in the 15-week group (p=0.06, Figure 17D).  
 
 
(Next page) Figure 17. Proteolytic enzyme activity in mAtg7-/- muscle. A: Quantitative analysis 
of maximal caspase-3 enzymatic activity in the white gastrocnemius (WG) and red gastrocnemius (RG) 
of mAtg7-/- animals (KD) and Flox/Flox controls (CTRL). B: Quantitative analysis of maximal caspase-
8 enzymatic activity in the WG and RG of KD and CTRL animals. C: Quantitative analysis of maximal 
caspase-9 enzymatic activity in the WG and RG of KD and CTRL animals. D: Quantitative analysis of 
maximal calpain enzymatic activity in the WG and RG of KD and CTRL animals (n=6-8, * main effect 
p<0.05 vs. CTRL, †† main effect p<0.01 vs. 5-week group, ††† main effect p<0.001 vs. 5-week 
group). 
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Reactive oxygen species generation  
 To determine whether the redox environment of autophagy-deficient skeletal muscle 
was altered, reactive oxygen species (ROS) generation was quantified using the DCF assay. 
There were no significant differences in ROS generation between the four groups, across both 
WQ and RQ (Figure 18).  
 
Figure 18. ROS generation in mAtg7-/- muscle. A: Quantitative analysis of ROS generation (as 
determined by dichlorofluorescein fluorescence) in the white gastrocnemius (WG) of mAtg7-/- animals 
(KD) and Flox/Flox controls (CTRL). B: Quantitative analysis of ROS generation in the red 
gastrocnemius (RG) of KD and CTRL animals (n=7-8). 
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Discussion 
 The purpose of this project was to characterize the role of autophagy in the 
maintenance of skeletal muscle health at a cellular level. To determine this, morphological, 
proteolytic, and apoptotic measures were performed in a skeletal muscle-specific Atg7 
knockdown mouse model. As autophagy is a key regulator of muscle size and function, it was 
hypothesized that mAtg7-/- animals would display smaller muscles and muscle fibres, signs of 
muscle damage, as well as upregulated apoptotic and proteolytic markers. The role of 
mitochondrial signalling was of particular interest as a potential mediator of skeletal muscle 
degradation.  
Muscle-specific autophagy knockdown did not affect whole body or isolated muscle 
weights; however, the 15-week-old animals predictably had larger muscles and muscle fibres 
than the 5-week-old animals. At the fibre level, the mAtg7-/- animals exhibited differences in 
fibre type-specific cross-sectional area and fibre type distribution, as well as structural 
changes. As expected, Atg7 knockdown resulted in profound alterations to downstream 
autophagic markers, such as LC3 lipidation and p62 accumulation. Indicators of lysosomal 
activity remained unchanged with autophagy knockdown, likely because lysosomes are 
necessary for a number of other degradative processes independent of autophagy  [130]. While 
none of the measures of mitochondrial stress were affected by autophagy knockdown, there is 
evidence of increased apoptotic signalling in mAtg7-/- muscle. Together, these findings point 
towards modest but accumulative damage in autophagy-ablated skeletal muscle. Interestingly, 
decreased proteolytic activity with a concurrent upregulation of proteasomal markers was 
observed, highlighting a role for degradative and cell death processes in skeletal muscle 
growth and development.  
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The role of autophagy in the maintenance of skeletal muscle morphology 
 Autophagy is a necessary cellular process in the development and maintenance of 
tissues  [131]. Accordingly, early studies using autophagy-deficient mice found that they do 
not survive past the neonatal stage, once access to maternal nutrients is terminated  [132]. In 
skeletal muscle, autophagic dysregulation results in pathology, either through excess 
degradation  [97, 98], or conversely, the accumulation of damaged proteins and organelles  
[101, 102].  Evidence on the effect of autophagy disruption in skeletal muscle is equivocal. 
Using a similar constitutive Atg7 knockdown mouse model, Masiero and colleagues showed 
abated growth, degenerative muscle fibre alterations in tibialis anterior, and reduced isolated 
muscle force in gastrocnemius [116]. Using the same animal model, Kim and colleagues 
observed muscle fibre damage and atrophy in the gastrocnemius  [117]. Reduced psoas fibre 
diameter has also been reported using this model  [118]. These investigations used a Cre-loxP 
construct with Cre expression driven by the myosin light chain 1 fast (MLC1f) promoter. In 
contrast, in an Atg7 knockdown model using a muscle creatine kinase (MCK) promoter to 
drive Cre expression, no phenotypic differences were observed, and the soleus was free of 
histological muscle fibre abnormalities  [115]. In the present work, Atg7 knockdown driven by 
the alpha 1 actin promoter (ACTA1) did not result in any significant differences in body weight 
or isolated muscle weights. The genetic constructs used to knock down skeletal muscle 
autophagy may have contributed to the disparity in the results obtained with this model. While 
all the models of Atg7 deficiency studied to date made use of Cre-loxP recombination to target 
skeletal muscle autophagy, differing skeletal muscle-specific promoters were used to drive Cre 
expression. As its name indicates, MLC1f is the light chain isoform expressed in fast muscle 
fibres; similarly, MCK is expressed at a much higher level in fast-twitch fibres  [133]. Skeletal 
 52 
muscle actin 1, the protein product of the ACTA1 gene, is ubiquitously expressed in all skeletal 
muscle fibre types  [133]. In the MLC1f and MCK Cre models, higher expression of Cre in fast 
fibres may have exacerbated the effect of autophagy knockdown, as these fibre types have a 
greater level of basal autophagy  [134]. However, as murine muscle is primarily composed of 
fast muscle fibres, this effect is unlikely to explain the extent of the differences between the 
existing studies and this thesis  [122, 135]. The expression of these promoters may 
nevertheless vary with the age of the mice used , as creatine kinase and proteins of the 
contractile apparatus are differentially expressed throughout development  [136-138]. 
Unfortunately, the existing work on Atg7 knockdown mice did not include a quantification of 
the reduction in Atg7 protein expression, making comparison to the extent of the knockout 
impossible. Furthermore, while the majority of existing data on mAtg7-/- mice was compared to 
Flox/Flox control littermates, one study used Flox/WT/Cre controls [115], potentially adding 
to the disparity between studies.  
The present project demonstrated muscle fibre damage at a histological level in 
glycolytic muscle, with no significant effects seen in oxidative muscle. This is in agreement 
with previous characterization of muscle-specific autophagy knockdown mice: examinations of 
glycolytic muscle show increases in centralized nuclei  [116, 117], while oxidative muscle 
appears to be spared  [115]. Specifically, Masiero and colleagues found a 1.5% increase in 
centralized nuclei in the tibialis anterior muscle of 8-week-old mAtg7-/- mice [116], a 
comparable figure to that observed in EDL in this thesis. Wu and colleagues’ observations of 
lack of atrophy and damage in autophagy-deficient soleus were also corroborated [115]. 
Glycolytic muscle displays higher levels of basal autophagy  [134], and is more responsive to 
the induction of autophagy though exercise  [139]. It is possible that compared to oxidative 
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muscle, glycolytic muscle is more reliant on autophagy to maintain the cellular environment, 
both basally and in response to a stressor [140].  
This work is the first to quantify fibre type distribution and fibre type-specific CSA in 
autophagy-deficient muscle. Unexpectedly, there were no differences in total muscle cross-
sectional area in either muscle type; in fact, fibre type-specific CSA of type IIX fibres was 
increased in the knockdown animals in both muscle types. While these findings are 
paradoxical, a number of well-characterized myopathies and dystrophies present with fibre and 
whole-muscle hypertrophy, such as Duchenne muscular dystrophy  [141, 142]. In the case of 
autophagy-deficient mice, it is possible that the lack of autophagic degradation is contributing 
to the larger fibre size through the accumulation of protein aggregates. Alternatively, repair by 
satellite cells may be mitigating atrophy, an effect that has been observed in mdx mice, a 
murine model of human muscular dystrophy [143]. The atrophy characteristic of this condition 
is greatly delayed in these mice, partly due to an excellent regeneration capacity of satellite 
cells  [144]. In the present study, protective regeneration is supported by the presence of 
centrally located nuclei in the knockdown glycolytic muscle. In the soleus, autophagy 
knockdown resulted in a decrease in the proportion of slow oxidative type I and I/IIA fibres 
with a concurrent increase in the percentage of type IIX fast glycolytic fibres. Mouse muscle is 
composed predominantly of fast fibres, with a small proportion of slow oxidative fibres found 
mainly in the soleus  [122, 135]. The small shift of slower fibre types to faster, glycolytic types 
may be an early response to damage caused by autophagy deficiency  [145].  
The relationship between apoptosis and autophagy  
The closely related degradative processes of apoptosis and autophagy have been the 
subject of much investigation in a number of cell and physiological models. In cell culture 
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models – especially tumorigenesis studies – contrasting relationships between autophagy and 
apoptosis have been observed.  Some reports indicate that autophagic degradation prevents 
apoptosis by clearing harmful cellular debris, a connection shown through tumor cell apoptosis 
in response to autophagy inhibition [146, 147], or alternatively through the protection of cells 
from cell death following the induction of autophagy [148, 149]. In contrast, enhanced 
autophagy in HeLa cells through overexpression of Atg5 resulted in heightened susceptibility 
to apoptosis  [150]. 
Murine models of whole-body and tissue-specific autophagy ablation have shown a 
variety of deleterious effects  [151-153], including evidence of increased apoptotic signalling. 
The seminal global Atg7 ablation work by Masaaki Komatsu’s group showed increased 
TUNEL-positive staining in the liver, a marker of apoptotic DNA fragmentation [125]. 
Similarly, inducible cardiomyocyte-specific Atg5 knockdown increased TUNEL-positive cells  
[154]. Targeted Atg7 knockdown in erythroid cells resulted in increased cell death, measured 
by flow cytometry analysis of Annexin V staining  [155]. The only measure of apoptosis that 
has been performed in skeletal muscle-specific Atg7 knockdown mice is the quantification of 
apoptotic nuclei through terminal deoxynucleotidyltransferase-mediated dUTP nick end 
labelling (TUNEL), which were increased in autophagy-deficient gastrocnemius muscle  [116]. 
However, the localization of these apoptotic nuclei was not indicated, leaving unanswered the 
question of whether myonuclear or interstitial nuclei are responsible for this increase. 
Additionally, the significance of myonuclear apoptosis has been contested, pointing rather to 
alternate apoptotic signalling responsible for muscle mass loss [112]. As such, a more 
exhaustive characterization of these pathways was warranted. 
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 As the first characterization of apoptotic signalling in autophagy-deficient skeletal 
muscle, the present work contributes to existing knowledge of apoptotic signalling in response 
to autophagy disruption. Glycolytic muscle of knockdown animals had increased expression of 
the pro-apoptotic protein Bax, while oxidative muscle of the 15-week-old knockdown animals 
showed elevated translocation of AIF to the nucleus. Beclin-1 was also elevated in the 
glycolytic muscle of knockdown animals.  This protein is known to regulate both apoptosis 
and autophagy, and may represent a futile effort by the cell to upregulate autophagy  [11]. 
Together with the marked increase in autophagic byproducts such as p62 and LC3I, these 
findings point towards a moderate induction of apoptosis, potentially in response to autophagy 
knockdown.  The accumulation of proteins and organelles tagged for degradation presents a 
stress to the cell that can result in apoptosis  [41, 100]. This corroborates the theory that 
autophagy plays a protective role in skeletal muscle  [42]. 
This study also examined the activity of a number of proteolytic enzymes in 
autophagy-deficient muscle. In both oxidative and glycolytic muscle, caspase-8 activity was 
elevated, trending towards significance. The relationship between caspase-8 and autophagic 
degradation has been studied in apoptosis-deficient cancer cells. These colon carcinoma cells 
are resistant to cell death receptor-mediated activation of caspase-8 due to a cytoprotective 
autophagic response [156]. Inhibition of autophagy in these cells results in heightened caspase-
8 activity  [157]. Caspases also directly cleave proteins independent of myonuclear apoptosis, 
specifically targeting actin [111]. These large molecules are broken down into smaller 
fragments suitable for degradation by the proteasome, contributing to this pathway of muscle 
degradation  [109, 110]. 
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mAtg7-/- glycolytic muscle showed increased activity of calpains, proteolytic enzymes 
activated by increased cytosolic calcium to cleave a number of protein targets  [158]. In the 
absence of autophagy, an accumulation of misfolded proteins may be responsible for the 
release of calcium from the ER to the cytosol and subsequent calpain activation  [38]. There 
was no effect of the knockdown on calpain activity in oxidative muscle, but AIF translocation 
to the nucleus was increased, further suggesting the involvement of ER stress and caspase-
independent apoptosis in this model. Calpains may also play a role in autophagic signalling 
and its cross-talk with apoptosis. Calpain-deficient cells have demonstrated a reduced 
autophagic response, indicating an alternate role for these enzymes  [159]. Calpains have 
further been implicated in the cellular switch between autophagy and apoptosis through the 
cleavage of Atg5 [150, 160]. Together, the caspase-8 and calpain responses seen in autophagy-
deficient muscle may point towards a compensatory mechanism of proteolysis in the absence 
of autophagic degradation.  
The mitochondrial response to skeletal muscle-specific autophagy knockdown 
Mitochondrial signalling was examined as a potential pathway contributing to the 
upregulation of some apoptotic markers observed in this study. Mitochondria are well 
established as an integral part of skeletal muscle health and function  [161]. However, in a 
‘chicken and egg’ type of problem, it remains unclear if damage-inducing stimuli causes 
mitochondrial dysfunction, or whether apoptotic and oxidative factors released by the 
mitochondria contribute to muscle damage  [88, 89]. Electron microscopy evidence of the 
accumulation of abnormal mitochondria has been observed in autophagy-deficient tibialis 
anterior and soleus  [115-117]. A further characterization of mitochondrial dysfunction in 
muscle-specific Atg7 knockdown mice revealed changes in the expression of oxidative 
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phosphorylation components and a reduction in ATP content  [115]. ROS generation was also 
found to be elevated in Atg7-null mouse embryonic fibroblasts (MEF) [115]. Nonetheless, this 
thesis’ experiments did not show the increased ROS generation expected based on the existing 
literature. The DCF assay used to ascertain this reflects changes in the overall oxidative 
environment in the cell; a mitochondrial-targeted measure of oxidative stress may reveal 
differences associated with autophagy knockdown. 
Mitophagy is a mechanism by which the cell can protect itself from the effects of 
dysfunctional or damaged mitochondria. Global Atg7 knockdown manifested in the liver with 
cellular abnormalities, including deformed mitochondria  [125]. Damaged mitochondria also 
accumulated in autophagy-null erythroid cells  [155]. In a model of cells exposed to toxic 
metabolites, the mitophagic elimination of damaged mitochondria reduced oxidative stress  
[162]. Similarly, neuronal cells were protected from neurodegenerative cell death following the 
induction of autophagy and mitophagy by staurosporine  [163]. The present study showed a 
moderate increase in apoptotic signalling, but it is difficult to discern whether this stress 
originates from the accumulation of dysfunctional mitochondria. Markers of mitochondrial-
mediated apoptosis, such as cytosolic cytochrome c release and caspase-9 activation, were 
non-significantly elevated in knockdown animals, possibly indicating mitochondrial stress. 
Investigations using mitochondrial respirometry and electron microscopy will be able to 
further elucidate the effect of autophagy disruption on mitochondrial signalling. 
While mitophagy and autophagy share key effectors and upstream activators, there is 
evidence that these processes are differentially modulated. In yeast, mitophagic degradation 
has been shown to be a separate event from bulk autophagy in response to starvation [164], 
and involves specific mitochondrial tagging proteins [165, 166]. Distinct ubiquitin-conjugating 
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enzymes have also been associated with the induction of mitophagy [167]. This may also 
include effectors specific to the mitophagic machinery. PINK1 was first identified as having a 
role in a mitophagic response mitochondrial membrane potential loss  [74, 168], but it has also 
been shown to inhibit mitophagy once cleaved from healthy mitochondria by binding Parkin in 
the cytosol and preventing its translocation to the OMM  [169]. Quantification of PINK1 in the 
cytosol of autophagy-deficient mice did not show any differences compared to control animals, 
suggesting that mitophagic signalling may not be contributing to the upregulated markers of 
apoptosis and structural alterations observed in the present model.  
Muscle-specific ubiquitin ligases as an alternative degradative pathway 
In conditions of cellular stress, the ubiquitin-proteasome system (UPS) is activated in 
concert with the autophagy-lysosome system  [170, 171]. While there is extensive evidence of 
the compensatory upregulation autophagy following the proteasomal inhibition  [172, 173], the 
reverse is not as clearly determined. In colon cancer cells, RNA interference and 
pharmacological inhibition of autophagy caused the upregulation of proteasomal degradation  
[174]. Evidence from previous work in autophagy-deficient muscle shows increased mRNA 
expression of MuRF1 and MAFbx in tibialis anterior [116]. Conversely, inhibition of 
autophagy has also been shown to inhibit the clearance of proteasomal substrates, a 
phenomenon thought to be caused by p62 accumulation [175]. The results of this study serve 
only to add to the debate; MuRF1 and MAFbx expression were not different between 
autophagy-deficient animals and controls. Further investigation into the crosstalk taking place 
between autophagic machinery and the UPS will help to elucidate whether varying types of 
muscle damage differentially activate these degradative pathways. 
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Developmental modulation of skeletal muscle degradative pathways  
While the effects of Atg7 knockdown in skeletal muscle were varied, there were clear 
differences between the 5-week and the 15-week-old groups in several measures. This included 
a logical increase in whole-body weight, isolated muscle weights, and fibre CSA associated 
with growth. Existing data on muscle-specific autophagy-deficient mice shows an age-
dependent increase in structural abnormalities and accumulation of autophagic markers. 
Specifically, the reduction in gastrocnemius force was greater in 5-month-old mice compared 
to 2-month-old mice, as was the proportion of centralized nuclei in the tibialis anterior  [116]. 
The present work was in agreement with these findings: the accumulation of p62 and LC3 was 
exacerbated in the 15-week-old group, as was the presence of centralized myonuclei in 
glycolytic muscle. Furthermore, while body weight did not differ significantly with autophagy 
deficiency, growth from 5 weeks to 15 weeks was abated in mAtg7-/- animals. It remains to be 
determined whether mAtg7-/- muscle is eventually able to adapt to this accumulative effect of 
autophagy deficiency. 
The age groups used in the present study represent two distinct stages in postnatal 
muscle development. In developing murine muscle, growth is a result of the addition of new 
myonuclei and the expansion of the cytoplasmic domains associated with them. These new 
myonuclei are provided by satellite cells, muscle progenitor cells  [176]. In mice, proliferation 
of satellite cells peaks during the first 3 weeks postnatally. Following a decline, the majority of 
satellite cells become quiescent by 6 to 8 weeks of age  [177]. Thus, animals in the 5-week age 
group are still increasing myofibre size, while the 15-week-old mice are considered to have 
fully developed adult muscle. Interestingly, while growth was evident in increased isolated 
muscle weights and fibre CSA measurements in the 15-week age group, the overall muscle 
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CSA was unchanged with age. The increases in isolated muscle weights are likely driven by 
longitudinal growth, which would not be observed in the cross-sectional area measurements.  
Multiple markers of proteolytic degradation were downregulated in the 15-week-old 
age group compared to the 5-week-old animals, including the activity of all measured casapses, 
calpain, and cathepsin. Caspases are critical in the development of a number of tissues [178, 
179], and the action of caspases is required for cellular proliferation and the control of tissue 
growth  [180]. In fact, generalized inhibition of caspases disrupts development and can causes 
embryonic death  [179]. The differentiation of skeletal muscle from muscle progenitor cells to 
myofibres requires caspase-3 to cleave protein kinase targets, thereby activating them. A more 
modest, but similar, increase in caspase-8 activity is also seen during differentiation [181]. 
Muscle-specific ubiquitin ligases MuRF1 and MAFbx are known to be upregulated in aging 
animals [182, 183]. While the 15-week-old age group in this project are not considered to be 
‘aging’, it is possible that adult muscle undergoes higher levels of basal proteosomal 
degradation than that of young animals. Research into the developmental role of muscle-
specfic ubiquitin ligases is limited, but suggests modulation in the embryonic and postnatal 
periods [184]. The downregulation of proteolytic enzymes and concurrent upregulation of 
proteasomal markers in the 15-week-old group may also indicate a counterbalance between 
these processes over the course of development. 
It is clear that autophagy also plays many important roles during embryonic 
development and post-natal growth  [125]. Knockdown of a variety of autophagic regulators in 
transgenic mouse models shows diverse defects and developmental problems, from embryonic 
lethality to specific health problems in adulthood [185]. Beclin-1 and LAMP2 were found to 
be downregulated in the 15-week-old animals in the present study. In the case of Beclin-1, 
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there is evidence that its interaction with other autophagic and apoptotic regulatory proteins 
may be altered during development. Similarly, apoptosis is regulated over the course of the 
mammalian lifespan [186]. In this characterization, the Bax:Bcl-2 ratio was decreased in the 
15-week-old age group. Together with the variation in proteasomal and proteolytic markers, 
these results point to differential regulation of degradative processes throughout development. 
Study limitations 
While tissue-specific autophagy knockdown models have been used extensively to 
circumvent the lethality of global autophagy knockout, it remains that Cre-loxP constructs do 
not achieve complete ablation of the target gene  [123]. The remaining Atg7 expression in this 
mouse model may have contributed to the modest effect of the knockdown seen in many of the 
measures performed. Residual Atg7 expression has been noted in all the existing studies using 
this model, but the extent of this has not been quantified. Complete autophagy inhibition could 
potentially be achieved by administering chemical inhibitors of autophagy to mAtg7-/- mice 
(e.g. 3-methyladenine, bafilomycin); however, these compounds would achieve whole-body 
autophagy inhibition, negating the skeletal muscle specificity of this model [187]. 
Quadriceps, gastrocnemius, soleus, and EDL were used in the study as representative 
oxidative and glycolytic muscle. Due to the relatively small size of these tissues, immunoblots, 
enzymatic measures, and histological analyses were performed on different muscle. This may 
have led to some disparity in the comparisons between muscle types. Similarly, some specific 
measures were not possible due to lack of sample. In the future, pooled muscle samples would 
help resolve this problem. 
Obstacles in the measurement of autopahgic flux remain, particularly regarding LC3 
immunoblotting. The study of autophagy using single-timepoint measures, such as the ones in 
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this project, only provide a snapshot of a constantly ongoing process. For example, while a 
decreased LC3II:I ratio is generally accepted as an indication of autophagic impairment, it can 
also be an indication of decreased LC3II degradation caused by rapid lysosomal turnover 
[188]. LC3 has also been found associated with non-autophagosomal structures, and may be a 
less specific measure than was previously thought [189]. In the present project, LC3 measures 
were interpreted in conjunction with Atg7 and p62 data in order to strengthen the analysis. 
Furthermore, previous investigations using the mAtg7-/- model corroborate this autophagy 
deficiency with evidence of p62 and LC3I accumulation [115-117], as well as fluorescent 
microscopy measures of autophagic flux using GFP-tagged LC3 [116].  
Future directions 
While it has been established that autophagy deficiency affects the morphology and 
maintenance of skeletal muscle, further examination of this model would be beneficial. The 
growth of mAtg7-/- mice has been tracked for the first 40 days of life  [116], but a 
characterization of the aging process in these animals remains to be examined. Autophagy is 
known to decline in aging skeletal muscle, therefore a characterization of aged autophagy-
deficient skeletal muscle may reveal the mechanisms behind this change [190]. Similarly, 
some measures of force have been reported in skeletal muscle-specific autophagy deficient 
mice  [116, 118], but a complete set of force measurements is needed to further our 
understanding of the functional effect of the knockdown.  
mAtg7-/- mice have been subjected to denervation in the study by Masiero and 
colleagues, showing a increased atrophy and degradation in the knockdown muscle [116]. 
However, the effect of other known muscle stressors should be examined. Chemical inducers 
of muscle damage such as doxorubicin will reveal how autophagy-deficient muscle will 
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contend with this type of stress  [97]. Exercise is known to induce autophagy in skeletal 
muscle [101, 104, 191], and is another challenge to autophagy-deficient animals that has yet to 
be fully explored. Autophagy may play a protective or adaptive role in response to exercise 
[140], possibly by contributing to protein turnover. These experiments will broaden our 
understanding of the role of autophagy in the plasticity of skeletal muscle. 
Conclusion 
The purpose of this thesis was to characterize the role of autophagy in the maintenance 
of skeletal muscle health. Using a skeletal muscle-specific Atg7 knockdown mouse model, 
autophagic, mitophagic, apoptotic, and proteosomal pathways were investigated in order to 
ascertain their role in mediating muscle morphology. While overt phenpotypic differences 
were absent between the knockdown animals and the controls, structural alterations were 
observed at the fibre level indicating moderate damage. A coinciding upregulation of some 
markers of apoptotic signalling suggests that autophagy ablation is detrimental to skeletal 
muscle. Several age-based alterations, specifically in the proteolytic and proteosomal 
pathways, emphasize the varying role of degradative processes over the course of the lifespan. 
Collectively, the present work contributes to the existing literature demonstrating the 
importance of autophagy in the maintenance of skeletal muscle health.  
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Appendix 
 
Appendix Figure 1. Use of Flox/Flox littermates as controls. White gastrocnemius samples were 
used to compare Flox/Flox control animals (FF) to Cre-negative (WT) and -positive (CRE) animals. A: 
Quantitative analysis and representative immunoblots of Atg7 and p62 protein expression in FF, WT, 
and CRE animals. The p62 blot is a reprobe of the Atg7 blot. B: Quatitative analysis and representative 
immunoblots of apoptotic proteins Bcl-2 and Bax expression in FF, WT, and CRE animals. Ponceau-
stained membranes are shown as loading and transfer controls (n = 6). 
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Appendix Figure 2. Immunohistological analyses of Flox/Flox control animals. Soleus (SOL) 
and extensor digitorum longus (EDL) cross-sections were used to compare morphological 
characteristics between Flox/Flox control animals (FF), Cre-negative (WT), and Cre-positive (CRE) 
animals. A: Total muscle cross-sectional area in SOL and EDL. B: Fibretype distribution in SOL and 
EDL as a percentage of total fibres. C: Fibre type-specific cross-sectional areas in SOL and EDL. (n = 
4-6). 
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Appendix Figure 3. Validation of red and white muscle isolation procedure. Whole quadriceps 
muscles were visually separated into primarily red and primarily white sections. Mixed muscle was 
discarded. A: representative image of whole and separated quadriceps muscle, as well as isolated soleus 
and EDL. B: Representative immunoblots of mitochondrial markers in white quadriceps (WQ) and red 
quadriceps (RQ). A Ponceau-stained membrane is shown as a loading and transfer control. 
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Appendix Figure 4. Skeletal muscle specificity of Atg7 knockdown. Left ventricle (LV) samples 
were used to ensure that Atg7 knockdown was limited to skeletal muscle. A: Quantification of Atg7 
protein expression in the white quadriceps (WQ), red quadriceps (RQ), and LV of control (CTRL) and 
Atg7-ablated animals (KD). B: Representative immunoblot of Atg7 protein expression in the WQ, RQ, 
and LV of CTRL and KD animals. A Ponceau-stained membrane is shown as loading and transfer 
controls (n = 6) 
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Appendix Figure 6. Use of extensor digitorum longus and soleus as representative white and 
red muscles. Extensor digitorum longus (EDL) and soleus (SOL) were used as white and red 
representative muscles, respectively, for cross-sectioning and histological examination. Representative 
immunoblots of mitochondrial markers in the SOL and EDL of control (CTRL) and Atg7-ablated 
animals (KD). Ponceau-stained membranes are shown as loading and transfer controls. 
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Appendix Figure 6. Atg7 knockdown in extensor digitorum longus and soleus. Extensor 
digitorum longus (EDL) and soleus (SOL) were used for cross-sectioning and histological examination. 
A: Quantification of Atg7 protein expression and representative immunoblots in the EDL of control 
(CTRL) and Atg7-ablated animals (KD). B: Quantification of Atg7 protein expression and 
representative immunoblots in the SOL of control (CTRL) and Atg7-ablated animals (KD). Ponceau-
stained membranes are shown as loading and transfer controls. (n = 2-4, * p<0.05, *** p<0.001). 
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Appendix Figure 7. Validity of the subcellular fractionation procedure. Fraction purity 
confirmation in white and red quadriceps. A: Representative immunoblots in white quadriceps (WQ) of  
CuZnSOD as a cytosolic market, histone H2B as a nuclear marker, and ANT as a mitochondrial 
marker. B: Representative immunoblots in red quadriceps (RQ) of CuZn SOD, histone H2B, and ANT.  
Ponceau-stained membranes are shown as loading and transfer controls. Lanes are labeled C 
(cytosolic), N (nuclear), M (mitochondrial). 
